Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Rat-neurotrophic-factor-receptor-GFR-x3b1-4

 Mammalian haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof
1. Hemoglobin derivative compatible with human and non-human animal plasma, comprising hemoglobin ...


 Anti hepatitis C virus antibody and uses thereof
OF THE PRESENT INVENTION Accordingly, the technical problem of the invention is to provide means ...


 Chemical and/or biological decontamination system
OF THE INVENTION The present invention provides a composition that is effective in the ...


 Immunostimulant bacterial membrane fractions in cancer treatment
The invention claimed is: 1. A method of stimulating an immune response and/or inducing an ...


 Cloning and characterization of a human adenylyl cyclase
One aspect of the invention is an isolated and purified human type VI adenylyl cyclase (hAC6) ...


 Tumor antigen based on products of the tumor suppressor gene WT1
What is claimed is: 1. An isolated polypeptide which consists of at most 12 contiguous amino acid ...


 Methods of inhibiting GPR-9-6 function
The invention relates to an antibody (immunoglobulin) or functional fragment thereof (e.g., an ...


 Method for cloning of a rare, specifically mutated cell
The invention is a new and improved method for reliably detecting the presence of a rare cell ...


 Vaccine against Gram-negative bacterial infections
OF THE PREFERRED EMBODIMENTS According to the present invention, a non-covalent, polyvalent ...


 Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin
The present invention relates to modified .beta.-chains of human hemoglobin having an oxygen ...


 Rat neurotrophic factor receptor, GFRα-4

Details
Inventors: Masure, Stefan L. J.; Cik, Miroslav; Hoefnagel, Evert W.;
Assignee: Janssen Pharmaceutica N.V. (Beerse, BE)
Primary Examiner: Hayes; Robert C.
Assistant Examiner:
Attorney, Agent or Firm: Donnelly; Laura

There is disclosed a novel mammalian receptor protein designated GFRα-4 and the nucleic acid sequence encoding therefor. Also provided is an expression vector comprising the nucleic acid sequence and host cells transformed or transfected with the vector. Host cells expressing the receptor may be used to identify agonists or antagonists in relation to the receptor.

DETAILED DESCRIPTION OF THE INVENTION Thus, the present invention relates to a nucleic acid molecule encoding a mammalian GDNF family receptor α-4 (GFRα-4) or an immunologically and/or biologically active fragment thereof, which comprises a nucleotide sequence selected from the group consisting of (a) nucleotide sequences encoding the polypeptide comprising the amino acid sequence depicted in SEQ ID NO: 8 or 9; (b) nucleotide sequences comprising the coding sequence as depicted in SEQ ID NO: 5 or 6; (c) nucleotide sequences encoding a polypeptide derived from the polypeptide encoded by a nucleotide sequence of (a) or (b) by way of substitution, deletion and/or addition of one or several amino acids of the amino acid sequence encoded by the nucleotide sequence of (a) or (b); (d) nucleotide sequences the complementary strand of which hybridizes with a nucleotide sequence of any one of (a) to (c); (e) nucleotide sequences encoding a polypeptide the amino acid sequence of which has an identity of 30% or more to the amino acid sequence of the polypeptide encoded by a nucleotide sequence of any one of (a) to (d); (f) nucleotide sequences encoding a polypeptide capable of binding persephin comprising a fragment or an epitope-bearing portion of a polypeptide encoded by a nucleotide sequence of any one of (a) to (e); (g) nucleotide sequences comprising at least 15 consecutive nucleotides of a nucleotide sequence of any one of (a) to (f) and encoding a polypeptide capable of binding persephin; and (h) nucleotide sequences comprising a nucleotide sequence which is degenerated as a result of the genetic code to a nucleotide sequence of any of (a) to (g).
Advantageously, the nucleic acid molecule according to the invention may be used for expression of said GFRα-4 protein in, for example, a host cell or the like, using an appropriate expression vector.
Preferably, the nucleic acid molecule is a DNA molecule, and even more preferably a cDNA molecule having a sequence as illustrated in any of Sequence ID No's



Related patents
  Polypeptide and protein derivatives and process for their preparation
What we claim is: 1. A method of producing a composition containing modified protein or polypeptide molecules, or salts thereof, wherein said modified protein or ...
  Single chain MHC complexes and uses thereof
The present invention relates to novel complexes of major histocompability complex (MHC) molecules (class I or II), e.g., empty single chain MHC class II complexes, ...
  IL-1/TNF-.alpha.-activated kinase (ITAK), and methods of making and using the same
The present invention provides nucleic acid and amino acid sequences of protein kinases, preferably human, that interact with at least one post-receptor intracellular ...
  DNA encoding IL-1 receptor accessory protein
What is claimed is: 1. An isolated polynucleotide comprising SEQ ID NO:1 wherein the nucleic acid at 1792 is A or C. 2. An isolated polynucleotide comprising a nucleic ...
  Human immunodeficiency virus immunogenic composition
The present invention relates to an HLA-based vaccine against HIV. Vaccines of the invention, which induce salutary anti-HIV immune responses, can be designed based on ...
  Recombinant molecule encoding human protease nexin
We claim: 1. An isolated DNA molecule which encodes mature protease nexin-I (PN-I) alpha of FIG. 3 or PN-I beta of FIG. 4 or encodes a PN-I protein encoded by a gene ...
  Method for design of substances that enhance memory and improve the quality of life
I claim: 1. Each of the compounds Gln Phe Phe-.gamma.-aminobutyric acid (SEQ ID NO: 20) Gln Phe Phe-.beta.-alanine (SEQ ID NO: 21) Gln Phe Phe-.delta.-aminovaleric acid (...
  Amyloid .beta. protein (globular assembly and uses thereof)
What is claimed is: 1. An isolated, soluble, non-fibrillar amyloid .beta. protein assembly comprising 3-12 amyloid .beta. proteins, wherein the amyloid .beta. protein is ...
  Chlamydia antigens and corresponding DNA fragments and uses thereof
The present invention provides purified and isolated polynucleotide molecules that encode the Chlamydia polypeptide designated 76 kDa protein (SEQ ID No: 1) which can be ...
  Methods of treating inflammatory bowel disease using cholera toxin B subunit
What is claimed is: 1. A method of treating inflammatory bowel disease in a subject diagnosed with inflammatory bowel disease, comprising administering to the subject a ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved